Detalhe da pesquisa
1.
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
N Engl J Med
; 378(8): 731-739, 2018 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29466156
2.
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.
Lancet Oncol
; 19(5): 705-714, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29606586
3.
The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas.
Cancer
; 124(21): 4241-4247, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30204247
4.
ENGAGE- 501: phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphoma.
Haematologica
; 101(8): 968-75, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27151994
5.
Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.
Ann Rheum Dis
; 74(6): 1102-9, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24812287
6.
Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial.
Clin Cancer Res
; 26(7): 1586-1594, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32034072
7.
Biological Effects of Anti-Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Antibody Formation in Patients Treated With GM-CSF (Sargramostim) as Adjuvant Therapy of Melanoma.
Am J Clin Oncol
; 40(2): 207-213, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25286079
8.
Low-dose outpatient chemobiotherapy with temozolomide, granulocyte-macrophage colony stimulating factor, interferon-alpha2b, and recombinant interleukin-2 for the treatment of metastatic melanoma.
J Clin Oncol
; 23(35): 8992-9000, 2005 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-16260693
9.
Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial.
RMD Open
; 2(1): e000197, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26958364
10.
The interplay of epigenetic therapy and immunity in locally recurrent or metastatic estrogen receptor-positive breast cancer: Correlative analysis of ENCORE 301, a randomized, placebo-controlled phase II trial of exemestane with or without entinostat.
Oncoimmunology
; 5(11): e1219008, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27999738
11.
The effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet recovery in breast cancer patients undergoing autologous bone marrow transplantation.
Exp Hematol
; 30(9): 1044-50, 2002 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12225796
12.
Phase II study of nab-paclitaxel and bevacizumab as first-line therapy for patients with unresectable stage III and IV melanoma.
Am J Clin Oncol
; 38(1): 61-7, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25616203
13.
EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer.
J Clin Oncol
; 33(14): 1609-19, 2015 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25847941
14.
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.
Neuro Oncol
; 17(6): 854-61, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25586468
15.
Pharmacodynamic stimulation of thrombogenesis by angiotensin (1-7) in recurrent ovarian cancer patients receiving gemcitabine and platinum-based chemotherapy.
Cancer Chemother Pharmacol
; 71(4): 965-72, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23370663
16.
Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal aromatase inhibitor.
J Clin Oncol
; 31(17): 2128-35, 2013 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23650416
17.
Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF, sargramostim) administered for 3 years as adjuvant therapy of stages II(T4), III, and IV melanoma.
J Immunother
; 32(6): 632-7, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19483646
18.
A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease.
Blood
; 109(10): 4557-63, 2007 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17244684
19.
Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma.
Oncologist
; 10(2): 138-49, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15709216
20.
'Chemobrain' in breast carcinoma?: a prologue.
Cancer
; 101(3): 466-75, 2004 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15274059